The beginnings of transsphenoidal surgery date back over a century ago, when in 1907, Austrian neurosurgeon Dr. Hermann Schloffer carried out the first documented transnasal operation in a patient with a pituitary tumor.42,48,49 This procedure was subsequently performed by surgeons in Vienna, von Eiselsberg and Hochenegg, in 1908.42,52 A year later, in 1909, Theodor Kocher35,42 modified the transnasal approach by introducing submucosal resection for better visualization, and within the year, various other modifications were introduced by Allen Kanavel,33,42 Samuel Mixter, and Alex Quackenboss.42,43 It was also in 1909 that Harvey Cushing performed his first transsphenoidal surgery, adopting Schloffer's original technique, in a 38-year-old farmer with acromegaly at The Johns Hopkins Hospital.8 In 1910, Oskar Hirsch, a Viennese otorhinolaryngologist, originated his endonasal transseptal transsphenoidal approach.29,42 Hirsch dedicated his life's work to championing the endonasal approach until his death in 1965.41,42,45
Cushing continued to use the transsphenoidal approach via a sublabial route (Fig. 1) to the pituitary and treated 231 pituitary tumors using this technique between 1910 and 1925.28 Indeed, it has been well documented that up to the year 1929, Cushing had a clear preference for the transsphenoidal approach over the transfrontal operation for the treatment of pituitary adenomas.14,28,41,45 By this time, Cushing had performed 272 transsphenoidal procedures for various pathological conditions. Despite this apparent partiality, Cushing began to rethink the advantages afforded by the transsphenoidal route when compared with more standard, transcranial approaches.7,11,42,45 He became concerned that its limited access to suprasellar masses, particularly lesions with suprachiasmal extension, did not allow for complete resection of tumors.7,11,14,45 In light of this, he decided to pursue the group of chiasmal and suprachiasmal lesions that he felt were better explored using a transcranial method, and therefore, abruptly transitioned to a purely transcranial practice.7,28,42,45 Subsequently, Hirsch, who had been exiled from Austria by the Nazis, joined Hannibal Hamlin, a neurosurgeon in Boston, and continued to use the transsphenoidal approach in their private practice with continued success.20,21,30,31,42 Nonetheless, Hirsch remained an “obscure voice in the wilderness,” as described by Dr. Nicholas Zervas.54 By then, most neurosurgeons, influenced by Cushing's practice, also largely abandoned the use of the transsphenoidal approach.

Anatomical illustration depicting the transsphenoidal approach to the pituitary fossa using the midline, oronasal-rhinoseptal route through a sublabial incision, originally developed by Harvey Cushing in 1910, which was later adopted by Dott, Guiot, and Hardy. Reprinted with permission from Hardy and Wigser: J Neurosurg 23:612–619, 1965.
Because of this transition from transnasal to transcranial surgery, the transsphenoidal operation fell out of favor for the majority of the neurosurgery community for nearly 35 years. However, it was the contributions of 3 key surgeons, whose lineage can be traced back to Cushing, who resurrected and preserved the transsphenoidal approach. Norman Dott, who learned the transsphenoidal operation from Cushing, introduced the method to Gerard Guiot, who in turn, passed it on to Jules Hardy.38,39,42,45,51 In this paper, we present a historical review of the resurrection and preservation of transsphenoidal surgery, specifically Harvey Cushing's legacy, with a focus on the lineage that extends from Dott to Guiot to Hardy into modern-day transsphenoidal surgery.
Norman Dott of Edinburgh, Scotland
Born on the southern outskirts of Edinburgh, Scotland in 1897,32 Norman McOmish Dott (Fig. 2) was integral in promoting transsphenoidal surgery in Europe. In his early life, Dott had been an engineering apprentice before attending medical school in Edinburgh in 1919. He became a resident in the Royal Infirmary of Edinburgh, where he was awarded the Fellowship of the Royal College of Surgeons in Edinburgh and undertook research that included the effects of pituitary ablation, which led to his earning the Rockefeller Fellowship. It was through this fellowship that Dott spent November 1923 to June 1924 as Harvey Cushing's assistant at the Peter Bent Brigham Hospital in Boston (Fig. 3).32,34,45,53 Interestingly, Dott was actually hesitant to go to Boston when given the opportunity to work with Harvey Cushing. At the time, he had just been newly appointed as Assistant Professor at the Chalmers and Deaconess Hospitals in Edinburgh and was establishing the beginnings of his career. In his words, “I had just put my plate up.”47 It was due to Sir Walter Fletcher, secretary of the Medical Research Council in London, who convinced Dott that working with the great Harvey Cushing would be of benefit to him in the future, that Dott agreed to accept the Rockefeller Fellowship.47

Photograph of Norman Dott, one of many in a series taken by one of his patients, Miss Grace Allison. Dott performed a transsphenoidal pituitary tumor resection on Miss Allison. Reprinted with permission from Rush C, Shaw JF: With Sharp Compassion. Norman Dott: Freeman Surgeon of Edinburgh. Edinburgh: Aberdeen University Press, 1990.

Photograph of Harvey Cushing's surgical team at The Peter Bent Brigham Hospital in Boston. At the time, Norman Dott (standing in the back row to the far right), a surgeon from Edinburgh, Scotland was doing a fellowship with Cushing (seated in the center of the front row). It was during this time that Dott learned the sublabial transsphenoidal approach by observing Cushing's technique. He subsequently brought transsphenoidal surgery to Edinburgh. The signatures represent the identity and arrangement of each of the individuals in the photograph. Reprinted with permission from Rush C, Shaw JF: With Sharp Compassion. Norman Dott: Freeman Surgeon of Edinburgh. Edinburgh: Aberdeen University Press, 1990.
As Cushing's pupil, Dott observed and learned the sublabial transsphenoidal operation to access lesions of the sella. In the early months of his fellowship, Dr. Eric Dott (Norman Dott's brother) recollected Dott's experience with Cushing:
I remember him [Norman Dott] telling me that it seemed to go too slowly for him at first, there were too many showy, talkative young men there, who liked to push themselves into prominence, whereas Norman just worked quietly and patiently away. Cushing soon discovered his real talents though, and gave him work to do.47
Norman Dott's learning experience with “The Chief,” as he referred to Harvey Cushing, was a unique one. According to Dott:
He [Cushing] did no formal teaching of his staff. We learned from him by watching his face and hands and by absorbing his casual remarks. We learned so thoroughly that it amused and impressed the writer in later years to observe some of his disciples displaying unconsciously but most faithfully the Chief's personal attitudes and characteristic utterances in their own operating rooms as well as observing his technical routines with religious exactitude—such was the imprint of the hero worship that he evoked.13
In 1925, Dott and Dr. Percival Bailey14 reported their review of Cushing's 196 patients with pituitary tumors. Of these, 177 underwent transsphenoidal tumor removal and 19 underwent transfrontal resection. They concluded that
the object of this surgical procedure is not only to remove as much of the tumour as thought safe, but also to relieve the upward pressure of a lesion which cannot be removed entirely, and will inevitably continue to grow, by permitting the growth to enlarge downward. Only the operation from below can accomplish this object.14
…it is quite probable, nevertheless, that the transsphenoidal operation will always have a slightly higher operative mortality than the transfrontal procedure, from the occasional possibility of meningeal infection which it carries with it…the transfrontal operation can hold out little to a patient with an adenoma beyond an exploratory operation with possible temporary relief of pressure symptoms; and there is always the risk of further damage to the chiasm by direct trauma, which defeats the main purpose of the operation. The transsphenoidal procedure confers a large measure of relief whose duration is much longer, often extending over many years. When, therefore, a diagnosis of adenoma can be made with confidence, we believe there is no question that the first surgical step should be a sellar decompression with partial removal of the tumour from below.14
Cushing had largely abandoned the use of the transsphenoidal approach by the late 1920s, because of its intrinsic difficulty and his growing interest in learning the transcranial avenues to the sella. In the meantime, Dott returned to Edinburgh at the end of his apprenticeship and introduced the transsphenoidal procedure to his neurosurgical practice. It has been reported that although Cushing trained Dott in his transsphenoidal procedure, he personally instructed Dott “not to teach it to anyone else.”50 In 1939, Henderson,28 Dott's assistant in Edinburgh, compared the most common complications between the two procedures in a follow-up retrospective review of a series of 338 cases performed by Cushing. He concluded that there was “no essential difference in the operative mortality of the two procedures. The danger of meningitis after the transsphenoidal operation is counterbalanced by the slight risk of clot formation after the transfrontal operation.”28 This information seemed to reaffirm the integrity of the transsphenoidal operation for Dott, who thought that the approach had “fallen into rather undeserved neglect during recent years.”4 Professor Dott not only preserved and passed on Cushing's teachings, but he further enhanced the approach by developing a lighted nasal speculum retractor to provide better illumination in the deep, dark, narrow surgical field.36,38,39,45,53 By 1956, Dott had performed 120 transsphenoidal surgeries, with a 0% mortality rate in the final 80 consecutive patients.2,4,14,32,38,39,42,45,53
At the time of his death in 1973, in appreciation of Professor Dott, an observer remarked about the paucity of reports written by Dott regarding his scientific work because “his literary reticence was curious … he wrote well, and from his vast experience he certainly had much to write about …”32 Perhaps Dott wrote little about his experience with the transsphenoidal approach to respect his instructor's wishes, given that Cushing had asked him to refrain from passing on his teachings. In addition, at that time, the vast majority of the neurosurgical community mirrored Cushing's rejection of the transsphenoidal procedure as an accepted practice for chiasmal lesions.53 Conceivably, Dott did not want to undermine or insult Cushing's practice guidelines by making such literature available that promoted the use of the transsphenoidal approach.
It has been postulated that perhaps Dott's previous experience as a pediatric surgeon specializing in the correction of facial defects, such as the cleft palate, benefited him in improving the transsphenoidal approach. The skill set required in working on the delicate pediatric population afforded him the ability to work in the rather small, dark, and narrow operative corridor in transsphenoidal surgery.38,39 It can further be theorized that Dott's background in engineering allowed him to possess the level of meticulous attention to detail required during these procedures to achieve tremendous results with his patients. It is no secret that the seamlessness of Dott's surgeries and his postoperative results were both impressive and inspiring, especially to his Parisian student, Gerard Guiot.
Gerard Guiot of Paris, France
Gerard Guiot was a pioneering French neurosurgeon who promoted the revival of transsphenoidal surgery in France (Fig. 4).7,23,42,45,53 Guiot was born in Fourmies, a small town in northern France. After graduating from the Medical School of Paris in 1937, he became an assistant to Clovis Vincent, who had learned various procedures from Harvey Cushing in the US during the 1920s. It was through this relationship that Guiot received his place as Cushing's “spiritual grandchild.”23 Impressed with Dott's success with the transsphenoidal approach during his 2-week stay as a visiting observer at the Royal Infirmary in Edinburgh in 1956,17,18,53 Guiot reaffirmed the use of the transsphenoidal surgical approach in France. In 1957, Guiot began to use the transsphenoidal approach in Paris and introduced the x-ray film intensifier and fluoroscopy for intraoperative image guidance.32,36,42,45,53 These tools were among the most valuable contributions in the 1960s, because they allowed for improved delineation of the tumor contour and good visualization of instruments placed at the skull base.24

Photograph of Gerard Guiot, who resurrected the use of the transsphenoidal approach in France. Guiot was also pivotal in contributing intraoperative image guidance with image-intensifier fluoroscopy to further improve visualization during the transsphenoidal procedure. In this picture, he is playing an 18th century pipe wind organ, a gift from his wife, that he rebuilt in the back room of his barn after he retired in 1987. This photograph was published in Surg Neurol 11, Hardy J: Neurosurgeon of the year. Gerard Guiot, pp 1–2, copyright Elsevier, 1979. Reprinted with permission.
In 1959, Guiot wrote, “It is perhaps surprising today to propose the transsphenoidal route to extirpate certain tumours of the hypophysis … In France, notably, the intracranial route is used exclusively … the transsphenoidal route is practically forgotten … its advantages should be reconsidered and its indications retained.”16,45 A year later, in a report of his experience with the transsphenoidal procedure, he further stated, “Shouldn't one stop referring to this approach as ‘historic’ and ‘passé’? Isn't it right to admit its advantages and retain its indications? Without doubt.”18,42,45
In his practice, Guiot demonstrated with more than 1000 cases that the transsphenoidal approach was clearly statistically superior to the transcranial route for removal of pituitary adenomas. He was able to exhibit a lower rate of morbidity and better results with visual recovery in patients with suprasellar extension of their tumor.23 In his tribute to Guiot,23 Jules Hardy reported that Guiot was able to show that 90% of pituitary adenomas could be surgically removed via the transsphenoidal approach. In a separate oral presentation about the history of pituitary tumors and microneurosurgery,22 Hardy reflected upon the major challenges with pituitary surgery as described by his mentor, Gerard Guiot:
Although the complete removal of a pituitary adenoma might restore the previous hormonal deficit, one should agree this is rather exceptional. From this point of view one must say that the patient is rather endangered since the adenomatous tissue is not separable from the normal hypophyseal tissue and the attempt to perform a complete radical excision brings in the curettes the glandular tissue still functionally active. Therefore, this increases the hormonal deficit which can lead to a complete pituitary insufficiency following surgery.22
It was partly in response to this dilemma that Jules Hardy contributed the next major advancement in transsphenoidal surgery, the surgical microscope.
Despite the setbacks he encountered, Guiot continued to innovate by expanding the indications for the transsphenoidal approach and also by experimenting with new technology. He extended the use of the transsphenoidal approach to the sella to resect other tumors such as craniopharyngiomas, clival chordomas, and other parasellar lesions.10 Gerard Guiot is also credited as the first neurosurgeon to use the endoscope for transsphenoidal surgery, having used it in 1961.24 Guiot's endoscope was designed with an external light source that was supported on a rigid shaft.24 However, he abandoned its use because he felt that it did not provide adequate visualization during surgery.12,19 He did occasionally use the endoscope after removal of a tumor to examine the sellar floor for residual tumor tissue, a technique that Jules Hardy also adopted after training with Guiot at the Foch Hospital.24,37 Little did Guiot know that this innovation would eventually transform transsphenoidal surgery in the modern era.
Jules Hardy of Montreal, Canada
Back when I was in Paris with Guiot, he had just started to do transsphenoidal from a few years before in 1958. He went to Edinburgh where he learned that procedure from Dott, who learned from Cushing invariably. So, that was a third generation of professors, and I was very much influenced also. This is where I learned transsphenoidal by just watching as I was a senior resident, and Professor Guiot let me do several cases by myself…so when I came back to Montreal, I came back with … the transsphenoidal approach, which was not a new method, it was an old traditional, classical Cushing's operation.40

Photograph of Jules Hardy (right) and Gerard Guiot (left). Jules Hardy received the opportunity to become a fellow of the McLaughlin Foundation in Toronto, and traveled to France to study stereotaxic surgery under Gerard Guiot, who was a pioneer in the field. It was during this fellowship, that Hardy was unintentionally introduced to transsphenoidal surgery to access lesions in and around the sella. Reprinted from Transsphenoidal Surgery, ed 1, Laws ER, Lanzino G (eds), “History of transsphenoidal surgery for pituitary tumors,” Lanzino G, Catapano D, and Laws ER, pp 4–9, copyright 2010, with permission from Elsevier.

Photograph of Jules Hardy, who was a major figure involved in the revival of transsphenoidal surgery in North America. After learning Guiot's modified transsphenoidal approach in Paris, Hardy returned to Montreal, where he introduced the use of the surgical microscope to aid visualization during transsphenoidal operations. Hardy discovered that use of the operative microscope allowed him to differentiate between tumoral tissue and normal pituitary glandular tissue. Furthermore, he realized that he could also distinguish the anterior lobe of the gland from the posterior gland and thus was able to introduce the concept of selective adenomectomy. Reprinted from Surg Neurol 22, Molina-Negro P: Jules Hardy, M.D., pp 109–112, copyright 1984, with permission from Elsevier.
In 1962, Hardy returned to Notre-Dame Hospital in Montreal and continued to use Guiot's modified version of Cushing's transsphenoidal hypophysectomy in conjunction with preoperative encephalography and intraoperative radiofluoroscopy (Figs. 7 and 8).53

Operative drawings illustrating the oronasal, rhinoseptal, transsphenoidal approach via a sublabial incision first introduced by Harvey Cushing. A: Sublabial incision. B: Elevation of the nasal mucosa from the floor. C: Frontal view of submucosal dissection from the septum. D: Resection of the cartilaginous septum using a swiveled knife. E: Sagittal view of the submucosal dissection. F: After introduction of the subnasal speculum, the vomer is visualized, resembling the keel of a boat. G: Sagittal view of the position of the subnasal speculum during the operation. Reprinted with permission from Hardy: J Neurosurg 34:582–594, 1971.

Operative drawings illustrating the portion of the procedure after adequate access to the sella turcica has been achieved. A: View after resection of the vomer and floor of the sphenoid sinus, which allows for wide exposure of the cavity and sella turcica. B: Opening the floor of the sella. C: Cruciate incision of the sellar dura. D: Elevation of the dural flaps and initiation of the dissection of the gland at the superior surface in order to achieve the extracapsular plane of cleavage. E: Identification of the pituitary stalk. E-1: Horizontal anatomical section to illustrate the strict midline approach to the sella turcica. F: Low section of the stalk with blunt-ended scissors, done for total transsphenoidal hypophysectomy. Reprinted with permission from Hardy: J Neurosurg 34:582–594, 1971.
One of the many criticisms at the time about the transsphenoidal approach was that the surgical exposure was limited in its ability to allow adequate light and visualization by the surgeon, thereby preventing a complete or gross-total resection of tumors in the pituitary fossa. In 1965, Hardy and Wigser27 reported 20 cases of pituitary fossa tumors that were resected by means of a transsphenoidal approach to the sella using intraoperative televised radiofluoroscopy, which allowed complete removal of the tumor. They further described that with both preoperative and intraoperative diagnostic and radiological control, the removal of these tumors via the transsphenoidal route could result in good postoperative outcomes.27
No, I don't think I have contributed to the approach by itself. There is probably a little bit of misunderstanding when people repeat Jules Hardy's contribution. I have never claimed any improvement or anything that could be better than what Cushing had devised himself.… I think if I would be allowed to claim anything possibly that could be a little bit of an improvement…. my contribution, I think, is when I started to use the surgical microscope, which was an old ENT microscope. And I began to watch carefully what I was doing into the sella and I found that we could identify the normal gland embedded within the mass of tumor tissue. In the past … most agreed that it was impossible to distinguish between normal [gland] and tumor. And whenever we make a sellar cleanout, we remove everything, and all patients would develop panhypopituitarism. With the help of the surgical microscope, we could identify [the pituitary gland]. And that was the first step that I started to claim that we could do selective tumor removal with identification and preservation of the normal gland.40

Illustration of the operative setup that Hardy used for transsphenoidal surgery. This arrangement allowed him to simultaneously use the binocular operative microscope as well as televised intraoperative radiofluoroscopic guidance. Reprinted with permission from Hardy: J Neurosurg 34:582–594, 1971.

Operative drawing illustrating Hardy's selective removal of a pituitary microadenoma from the lateral wing of the gland in a patient with acromegaly. This operation involving selective removal of a pituitary microadenoma with preservation of the normal pituitary gland is perhaps one of Jules Hardy's most recognized contributions to transsphenoidal surgery. Reprinted with permission from Hardy: J Neurosurg 34:582–594, 1971.
… upsetting to me so that when I decided to use the surgical microscope, I soon became aware of a new fact: at higher magnification I was able to distinguish in some cases the residual normal pituitary gland quite separate from the tumoral tissue. As a result I decided to make all effort to preserve the pituitary to prevent new deficits.22

Photograph from Jules Hardy's personal collection showing Gerard Guiot (left) and Hardy (right) shaking hands. Guiot's mentorship and his impact on Hardy's neurosurgical practice is noteworthy. His guidance inspired Hardy to enrich the transsphenoidal operation with his own contributions. Reprinted from Neurosurg Clin N Am 14, Lanzino G, Laws ER Jr: Key personalities in the development and popularization of the transsphenoidal approach to pituitary tumors: an historical overview, pp 1–10, copyright 2003, with permission from Elsevier.
In 1968, Hardy and his assistant, Dr. Ivan Ciric,26 described a series of 17 cases involving patients with diabetic retinopathy who underwent selective anterior hypophysectomy with transsphenoidal microsurgical technique. They emphasized the utility of the operative microscope in visualization of the pituitary gland and the ability to differentiate between the anterior and posterior lobes based on the difference in color. The ability to see the morphological variation between the two lobes allowed greater accuracy and precision in the selective removal of the anterior lobe of the pituitary gland. Perhaps one of the most important advantages the microscope conferred was that it allowed the surgeon to ensure gross-total resection of the particular tumor or lesion.26 Dr. Ciric brought his knowledge to Chicago, where he performed the first transsphenoidal pituitary surgery in the US in November of 1967, using the operating microscope at Evanston Hospital.5,6,50 Interestingly, in the same year of 1967, just as Ciric was finishing his fellowship with Hardy, Dr. Charles B. Wilson visited Guiot in Paris to learn the transsphenoidal approach and subsequently performed the first transsphenoidal surgery at the University of California, San Francisco for a patient with acromegaly (in 1970).1,46
As Hardy's experience with transsphenoidal microsurgery grew over the years, he began to publish and describe specific indications for the transsphenoidal approach in the resection of skull base lesions. Using both the operating microscope and intraoperative fluoroscopic guidance, he was not limited to performing total hypophysectomies, but could also attempt removal of microadenomas, craniopharyngiomas, sellar and clival chordomas, and in rare instances, sellar meningiomas, melanomas, and granular cell tumors.3,9,25,42 In fact, it was Hardy who coined the term pituitary “microadenoma” in 1968—also referring to the lesion as the “pimento in the olive.”44 At the time, he was met with great skepticism from the rest of the neurosurgical community as well as by endocrinologists for his conclusions.44
Nevertheless, the transsphenoidal approach continued to be used over the next 40 years and was widely promulgated internationally. The approach has continued to evolve with the advent of technological innovations such as high-definition and 3D endoscopes, frameless stereotactic image-based guidance, intraoperative MRI, and extended transsphenoidal approaches to regions beyond the sella.15,42
Conclusions
The transsphenoidal approach might have been lost if not for the work of Harvey Cushing's dedicated disciple Norman Dott, who continued to use the approach and developed the lighted nasal speculum for its advancement. Dott's excellent results inspired Gerard Guiot to emulate his technique and improve it with the utilization of radiofluoroscopy for intraoperative image guidance. Guiot's fellow, Jules Hardy, avidly learned the approach and introduced the operative microscope, thus transforming the field with a new emphasis on microsurgery and selective adenomectomy. Through the work of these pioneering surgeons, the art of transsphenoidal surgery has been preserved and has continued to evolve with technological advances into the contemporary era. Today, it remains the preferred route to access sellar and parasellar lesions.
Disclosure
The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.
Author contributions to the study and manuscript preparation include the following. Conception and design: Liu. Acquisition of data: Patel, Husain. Analysis and interpretation of data: Liu, Patel, Husain. Drafting the article: Liu, Patel, Husain. Critically revising the article: all authors. Reviewed submitted version of manuscript: all authors. Approved the final version of the manuscript on behalf of all authors: Liu. Administrative/technical/material support: Patel, Husain. Study supervision: Liu, Eloy.
Acknowledgment
The authors thank Kristin Kraus, M.Sc., for editorial assistance with preparing this paper.
References
- 1↑
Andrews BT: Cherokee Neurosurgeon: A Biography of Charles Byron Wilson, M.D San Francisco, CreateSpace, 2011
- 2↑
Atkins HJ, , Falconer MA, , Bateman GH, & Dott N: Hypophysectomy for advanced cancer of the breast. Proc R Soc Med 56:389–398, 1963
- 3↑
Aubin MJ, , Hardy J, & Comtois R: Primary sellar haemorrhagic melanoma: case report and review of the literature. Br J Neurosurg 11:80–83, 1997
- 4↑
Biggart JH, & Dott NM: pituitary tumours: their classification and treatment. BMJ 2:1206–1208, 1936
- 5↑
Ciric I: History of neurosurgery at Evanston Hospital and NorthShore University HealthSystems. Dis Mon 57:538–542, 2011
- 6↑
Ciric I, , Leikin JB, & Rosseau GL: The rich history of neurosurgery at Evanston Hospital. Dis Mon 57:535–537, 2011
- 7↑
Cohen-Gadol AA, , Laws ER, , Spencer DD, & De Salles AA: The evolution of Harvey Cushing's surgical approach to pituitary tumors from transsphenoidal to transfrontal. J Neurosurg 103:372–377, 2005
- 8↑
Cohen-Gadol AA, , Liu JK, & Laws ER Jr: Cushing's first case of transsphenoidal surgery: the launch of the pituitary surgery era. J Neurosurg 103:570–574, 2005
- 9↑
Cohen-Gadol AA, , Pichelmann MA, , Link MJ, , Scheithauer BW, , Krecke KN, & Young WF Jr, : Granular cell tumor of the sellar and suprasellar region: clinicopathologic study of 11 cases and literature review. Mayo Clin Proc 78:567–573, 2003
- 10↑
Couldwell WT: Transsphenoidal and transcranial surgery for pituitary adenomas. J Neurooncol 69:237–256, 2004
- 11↑
Cushing H: Harvey Cushing: Selected Papers on Neurosurgery New Haven, Yale University Press, 1969
- 12↑
Doglietto F, , Prevedello DM, , Jane JA Jr, , Han J, & Laws ER Jr: Brief history of endoscopic transsphenoidal surgery—from Philipp Bozzini to the First World Congress of Endoscopic Skull Base Surgery. Neurosurg Focus 19:6 E3, 2005
- 13↑
Dott NM: Dr. Harvey Cushing, M.D. Memoir for the centenary year of his birth. Scott Med J 14:381–386, 1969
- 15↑
Gandhi CD, , Christiano LD, , Eloy JA, , Prestigiacomo CJ, & Post KD: The historical evolution of transsphenoidal surgery: facilitation by technological advances. Neurosurg Focus 27:3 E8, 2009
- 17↑
Guiot G, & Thibaut B: [Excision of pituitary adenomas by transsphenoidal route.]. Neurochirurgia (Stuttg) 1:133–150, 1959. (Fr)
- 18↑
Guiot G, , Thibaut B, & Bourreau M: [Extirpation of hypophyseal adenomas by trans-septal and trans-sphenoidal approaches.]. Ann Otolaryngol 76:1017–1031, 1959. (Fr)
- 19↑
Guiot J, , Rougerie J, , Fourestier M, , Fournier A, , Comoy C, & Vulmiere J, : [Intracranial endoscopic explorations.]. Presse Med 71:1225–1228, 1963. (Fr)
- 20↑
Hamlin H: The case for transsphenoidal approach to hypophysial tumors. J Neurosurg 19:1000–1003, 1962
- 22↑
Hardy J: History of pituitary tumors and microneurosurgery. Cyber History of Neurosurgery (http://www.neurosurgery.org/cybermuseum/microneurohall/jhardy.html) [Accessed June 26, 2012]
- 24↑
Hardy J, Reflections on the evolution of pituitary tumor surgery with emphasis on the transsphenoidal approach. Laws ER, & Lanzino G: Transsphenoidal Surgery Philadelphia, Saunders, 2010. 1–4
- 26↑
Hardy J, & Ciric IS: Selective anterior hypophysectomy in the treatment of diabetic retinopathy. A transsphenoidal microsurgical technique. JAMA 203:73–78, 1968
- 27↑
Hardy J, & Wigser SM: Trans-sphenoidal surgery of pituitary fossa tumors with televised radiofluoroscopic control. J Neurosurg 23:612–619, 1965
- 28↑
Henderson W: The pituitary adenomata. A follow-up study of the surgical results in 338 cases (Dr. Harvey Cushing's series). Br J Surg 26:811–921, 1939
- 29↑
Hirsch O: Endonasal method of removal of hypophyseal tumors. With a report of two successful cases. JAMA 55:772–774, 1910
- 30↑
Hirsch O: Life-long cures and improvements after transsphenoidal operation of pituitary tumors. (Thirty-three patients, followed-up for 20–37 years). Acta Ophthalmol Suppl 56:1–60, 1959
- 32↑
Horwitz NH: Library: historical perspective. Norman M. Dott (1897–1973). Neurosurgery 45:944–948, 1999
- 33↑
Kanavel A: The removal of tumors of the pituitary body by an infranasal route. A proposed operation with a description of the technic. JAMA 53:1704–1707, 1909
- 34↑
Kanter AS, , Dumont AS, , Asthagiri AR, , Oskouian RJ, , Jane JA Jr, & Laws ER Jr: The transsphenoidal approach. A historical perspective. Neurosurg Focus 18:4 e6, 2005
- 36↑
Landolt A, History of pituitary surgery. Greenblatt SH, , Dagi T, & Epstein M: A History of Neurosurgery in its Scientific and Professional Contexts Park Ridge, IL, American Association of Neurological Surgeons, 1997. 373–400
- 37↑
Lanzino G, , Catapono D, & Laws ER, History of transsphenoidal surgery for pituitary tumors. Laws ER, & Lanzino G: Transsphenoidal Surgery Philadelphia, Saunders, 2010. 4–9
- 38↑
Lanzino G, & Laws ER: Key personalities in the development and popularization of the transsphenoidal approach to pituitary tumors: an historical overview. Neurosurg Clin N Am 14:1–10, 2003
- 39↑
Lanzino G, & Laws ER: Pioneers in the development of transsphenoidal surgery: Theodor Kocher, Oskar Hirsch, and Norman Dott. J Neurosurg 95:1097–1103, 2001
- 40↑
Leaders in Neuroscience: An Archives Video-Interview Series. Jules Hardy interviewed by Roy C. Selby, MD. AANS, 2011 (feed://deimos3.apple.com/WebObjects/Core.woa/Feed/aans.org-dz.10334567665.010334567667) [Accessed June 26, 2012]
- 41↑
Liu JK, , Cohen-Gadol AA, , Laws ER Jr, , Cole CD, , Kan P, & Couldwell WT: Harvey Cushing and Oskar Hirsch: early forefathers of modern transsphenoidal surgery. J Neurosurg 103:1096–1104, 2005
- 42↑
Liu JK, , Das K, , Weiss MH, , Laws ER Jr, & Couldwell WT: The history and evolution of transsphenoidal surgery. J Neurosurg 95:1083–1096, 2001
- 43↑
Mixter SJ, & Quackenboss A: II. Tumor of the hypophysis (with infantilism). Ann Surg 52:15–22, 1910
- 46↑
Rosegay H: A history of neurological surgery at the University of California, San Francisco. Neurosurgery 38:794–805, 1996
- 47↑
Rush C, & Shaw JF: With Sharp Compassion: Norman Dott, Freeman Surgeon of Edinburgh Aberdeen, Scotland, Aberdeen University Press, 1990
- 48↑
Schloffer H: Erfolgreiche Operation eines Hypophysentumors auf nasalem Wege. Wien Klin Wochenschr 20:621–624, 1907
- 50↑
Stone JL, , Meglio G, & Laws ER: Development of pituitary surgery: the Chicago contributions. J Am Coll Surg 201:784–805, 2005
- 52↑
von Eiselsberg A: The operative cure of acromegaly by removal of a hypophysial tumor. Ann Surg 48:781–783, 1908
- 53↑
Welbourn RB: The evolution of transsphenoidal pituitary microsurgery. Surgery 100:1185–1190, 1986